BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38674062)

  • 1. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study.
    Camargo-Herrera V; Castellanos G; Rangel N; Jiménez-Tobón GA; Martínez-Agüero M; Rondón-Lagos M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines.
    Vargas-Rondón N; Pérez-Mora E; Villegas VE; Rondón-Lagos M
    Cancer Biol Med; 2020 Nov; 17(4):970-985. PubMed ID: 33299647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.
    Smid M; Hoes M; Sieuwerts AM; Sleijfer S; Zhang Y; Wang Y; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2011 Jul; 128(1):23-30. PubMed ID: 20632083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.
    Yanagawa M; Ikemot K; Kawauchi S; Furuya T; Yamamoto S; Oka M; Oga A; Nagashima Y; Sasaki K
    BMC Res Notes; 2012 Jul; 5():376. PubMed ID: 22830453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer.
    Burrell RA; Juul N; Johnston SR; Reis-Filho JS; Szallasi Z; Swanton C
    J Cell Biochem; 2010 Nov; 111(4):782-90. PubMed ID: 20665662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
    Jamal-Hanjani M; A'Hern R; Birkbak NJ; Gorman P; Grönroos E; Ngang S; Nicola P; Rahman L; Thanopoulou E; Kelly G; Ellis P; Barrett-Lee P; Johnston SR; Bliss J; Roylance R; Swanton C
    Ann Oncol; 2015 Jul; 26(7):1340-6. PubMed ID: 26003169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
    Voutsadakis IA
    Cancer Invest; 2021 Jan; 39(1):25-38. PubMed ID: 33306412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
    Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
    Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.
    Roylance R; Endesfelder D; Gorman P; Burrell RA; Sander J; Tomlinson I; Hanby AM; Speirs V; Richardson AL; Birkbak NJ; Eklund AC; Downward J; Kschischo M; Szallasi Z; Swanton C
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2183-94. PubMed ID: 21784954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.
    El Ansari R; Craze ML; Miligy I; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res; 2018 Mar; 20(1):21. PubMed ID: 29566741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers.
    Kawauchi S; Furuya T; Ikemoto K; Nakao M; Yamamoto S; Oka M; Sasaki K
    Oncol Rep; 2010 Oct; 24(4):875-83. PubMed ID: 20811667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions.
    Liu JC; Egan SE; Zacksenhaus E
    Oncotarget; 2013 Aug; 4(8):1317-28. PubMed ID: 23945331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.
    Mo H; Wang X; Ma F; Qian Z; Sun X; Yi Z; Guan X; Li L; Liu B; Xu B
    Breast; 2020 Oct; 53():111-118. PubMed ID: 32738630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
    Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
    Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centromere 17 copy number gain reflects chromosomal instability in breast cancer.
    Lee K; Kim HJ; Jang MH; Lee S; Ahn S; Park SY
    Sci Rep; 2019 Nov; 9(1):17968. PubMed ID: 31784614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying chromosomal instability from intratumoral karyotype diversity using agent-based modeling and Bayesian inference.
    Lynch AR; Arp NL; Zhou AS; Weaver BA; Burkard ME
    Elife; 2022 Apr; 11():. PubMed ID: 35380536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort study.
    Birkness JE; Spada NG; Miller C; Luketich JD; Nason KS; Sun W; Davison JM
    Genes Chromosomes Cancer; 2018 Jan; 57(1):28-34. PubMed ID: 28913947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes.
    Li JY; Jia S; Zhang WH; Zhang Y; Kang Y; Li PS
    Asian Pac J Cancer Prev; 2013; 14(5):3197-203. PubMed ID: 23803104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype.
    Zanardi E; Di Meglio A; Boccardo C; Zinoli L; Salvi S; Rubagotti A
    Oncol Res Treat; 2020; 43(7-8):362-371. PubMed ID: 32512573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.